Glaukos Gross Margin 2014-2026 | GKOS

Current and historical gross margin for Glaukos (GKOS) over the last 10 years. The current gross profit margin for Glaukos as of June 30, 2026 is %.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Glaukos Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2026-06-30 $0.61B $0.49B 78.99%
2026-03-31 $0.55B $0.43B 77.90%
2025-12-31 $0.51B $0.40B 77.76%
2025-09-30 $0.47B $0.36B 76.81%
2025-06-30 $0.43B $0.33B 76.21%
2025-03-31 $0.41B $0.31B 75.56%
2024-12-31 $0.38B $0.29B 75.26%
2024-09-30 $0.36B $0.28B 76.18%
2024-06-30 $0.34B $0.26B 76.32%
2024-03-31 $0.33B $0.25B 76.07%
2023-12-31 $0.31B $0.24B 76.11%
2023-09-30 $0.30B $0.23B 75.91%
2023-06-30 $0.30B $0.22B 75.68%
2023-03-31 $0.29B $0.22B 75.78%
2022-12-31 $0.28B $0.21B 75.62%
2022-09-30 $0.29B $0.22B 75.79%
2022-06-30 $0.29B $0.22B 76.47%
2022-03-31 $0.29B $0.23B 76.87%
2021-12-31 $0.29B $0.23B 76.87%
2021-09-30 $0.29B $0.22B 76.19%
2021-06-30 $0.28B $0.21B 74.65%
2021-03-31 $0.24B $0.16B 68.07%
2020-12-31 $0.23B $0.13B 59.56%
2020-09-30 $0.22B $0.13B 59.63%
2020-06-30 $0.21B $0.13B 63.21%
2020-03-31 $0.24B $0.18B 73.22%
2019-12-31 $0.24B $0.20B 83.61%
2019-09-30 $0.23B $0.20B 86.73%
2019-06-30 $0.21B $0.18B 86.73%
2019-03-31 $0.20B $0.17B 86.67%
2018-12-31 $0.18B $0.16B 86.19%
2018-09-30 $0.17B $0.15B 86.39%
2018-06-30 $0.17B $0.14B 86.67%
2018-03-31 $0.16B $0.14B 87.12%
2017-12-31 $0.16B $0.14B 87.42%
2017-09-30 $0.15B $0.13B 86.67%
2017-06-30 $0.14B $0.12B 86.43%
2017-03-31 $0.13B $0.11B 85.16%
2016-12-31 $0.12B $0.10B 85.22%
2016-09-30 $0.10B $0.09B 85.29%
2016-06-30 $0.09B $0.08B 84.62%
2016-03-31 $0.08B $0.07B 83.75%
2015-12-31 $0.07B $0.06B 81.94%
2015-09-30 $0.07B $0.05B 77.27%
2015-06-30 $0.06B $0.05B 76.27%
2015-03-31 $0.05B $0.04B 76.92%
2014-12-31 $0.05B $0.03B 75.56%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $10.092B $0.507B
Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $226.884B 25.75
Intuitive Surgical (ISRG) United States $133.518B 45.26
Edwards Lifesciences (EW) United States $49.242B 30.43
IQVIA Holdings (IQV) United States $43.729B 23.39
Waters (WAT) United States $40.283B 29.97
IDEXX Laboratories (IDXX) United States $40.144B 35.83
Alcon (ALC) Switzerland $33.505B 20.78
DexCom (DXCM) United States $31.955B 33.21
Mettler-Toledo (MTD) United States $25.762B 28.65
STERIS (STE) Ireland $20.832B 20.50
SONOVA HOLDING (SONVY) Switzerland $16.759B 0.00
Hologic (HOLX) United States $16.752B 17.53
Coloplast (CLPBY) Denmark $14.762B 17.70
Penumbra (PEN) United States $12.599B 83.08
Fresenius Medical Care AG KGaA (FMS) Germany $12.279B 8.59
Globus Medical (GMED) United States $10.173B 15.40
Masimo (MASI) United States $9.578B 30.69
SARTORIUS (SSSGY) Germany $7.521B 43.67
Sysmex ADR (SSMXY) Japan $7.390B 27.95
Teleflex (TFX) United States $5.521B 14.89
LivaNova (LIVN) United Kingdom $4.442B 22.46
Integer Holdings (ITGR) United States $4.287B 19.86
Pulse Biosciences (PLSE) United States $3.752B 0.00
Veracyte (VCYT) United States $3.313B 27.11
TransMedics (TMDX) United States $2.967B 43.58
AxoGen (AXGN) United States $2.354B 0.00
UFP Technologies (UFPT) United States $2.153B 27.17
Elekta AB (EKTAY) Sweden $1.883B 17.62
Nihon Kohden (NHNKY) Japan $1.694B 15.52
Alphatec Holdings (ATEC) United States $1.677B 0.00
Alpha Tau Medical (DRTS) Israel $1.301B 0.00
Integra LifeSciences Holdings (IART) United States $1.222B 6.36
Artivion (AORT) United States $1.217B 46.24
PROCEPT BioRobotics (PRCT) United States $1.204B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.171B 27.77
Tandem Diabetes Care (TNDM) United States $1.170B 0.00
OPKO Health (OPK) United States $1.164B 0.00
IRadimed (IRMD) United States $1.055B 46.11
Anteris Technologies Global (AVR) Australia $0.850B 0.00
SiBone (SIBN) United States $0.829B 0.00
Beta Bionics (BBNX) United States $0.753B 0.00
Mesa Laboratories (MLAB) United States $0.680B 16.37
AngioDynamics (ANGO) United States $0.641B 0.00
OrthoPediatrics (KIDS) United States $0.583B 0.00
Delcath Systems (DCTH) United States $0.570B 1644.00
Tactile Systems Technology (TCMD) United States $0.511B 20.90
NeuroPace (NPCE) United States $0.501B 0.00
Sight Sciences (SGHT) United States $0.448B 0.00
Pacific Biosciences Of California (PACB) United States $0.420B 0.00
ClearPoint Neuro (CLPT) United States $0.411B 0.00
908 Devices (MASS) United States $0.402B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.371B 0.00
Mobia Medical (MOBI) United States $0.334B 0.00
Semler Scientific (SMLR) United States $0.311B 2.32
Treace Medical Concepts (TMCI) United States $0.301B 0.00
Spectral Diagnostics (EDTXF) Canada $0.266B 0.00
RxSight (RXST) United States $0.254B 0.00
Neuronetics (STIM) United States $0.221B 0.00
Lucid Diagnostics (LUCD) United States $0.159B 0.00
FocalTherics (FOCL) France $0.154B 0.00
Inogen (INGN) United States $0.139B 0.00
EDAP TMS S.A (EDAP) France $0.124B 0.00
Microbot Medical (MBOT) United States $0.097B 0.00
LENSAR (LNSR) United States $0.096B 0.00
Hyperfine (HYPR) United States $0.085B 0.00
Zomedica (ZOMDF) United States $0.083B 0.00
CVRx (CVRX) United States $0.080B 0.00
QT Imaging Holdings (QTIH) United States $0.078B 0.00
Covalon Technologies (CVALF) Canada $0.071B 23.27
DarioHealth (DRIO) United States $0.069B 0.00
Positron (POSC) United States $0.059B 0.00
Rapid Micro Biosystems (RPID) United States $0.059B 0.00
Envoy Medical (COCH) United States $0.056B 0.00
Nano-X Imaging (NNOX) Israel $0.055B 0.00
Spectral AI (MDAI) United States $0.052B 0.00
Sensus Healthcare (SRTS) United States $0.052B 0.00
Precision Optics (POCI) United States $0.048B 0.00
Baird Medical Investment Holdings (BDMD) $0.045B 0.00
InspireMD (NSPR) United States $0.038B 0.00
QT Imaging Holdings (QTI) United States $0.036B 0.00
PAVmed (PAVM) United States $0.035B 0.00
Ekso Bionics Holdings (EKSO) United States $0.032B 0.00
Accuray (ARAY) United States $0.029B 0.00
Adagio Medical Holdings (ADGM) United States $0.010B 0.00
ENDRA Life Sciences (NDRA) United States $0.009B 0.00
EnVVeno Medical (NVNO) United States $0.007B 0.00
Nanovibronix (NAOV) United States $0.004B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
Bluejay Diagnostics (BJDX) United States $0.004B 0.00
Tenon Medical (TNON) United States $0.004B 0.00
ENvue Medical (FEED) United States $0.003B 0.00
Nuwellis (NUWE) United States $0.003B 0.00
NexGel (NXGL) United States $0.003B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.000B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.000B 0.00
WORK Medical Technology Group (WOK) China $0.000B 0.00